In every area of cancer treatment, there are specific therapeutic targets. The adverse event profile of any therapy is not well established. As more patients are treated with a developing therapy, it becomes obvious that we need to “keep our eyes wide open” to whatever CV events are possible. Once these are understood, strategies to identify these toxicities as well as optimal treatment strategies need to be devised. Drs. Mike Fradley and Joerg Herrmann explain.  - Acute Coronary Syndromes - 129_5feba5631406a

Understanding Tyrosine Kinase Toxicity | JACC: CardioOncology: GCOS 2019, Sao Paolo, Brazil

Understanding Tyrosine Kinase Toxicity | JACC: CardioOncology: GCOS 2019, Sao Paolo, Brazil

14 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

 

In every area of cancer treatment, there are specific therapeutic targets. The adverse event profile of any therapy is not well established. As more patients are treated with a developing therapy, it becomes obvious that we need to “keep our eyes wide open” to whatever CV events are possible. Once these are understood, strategies to identify these toxicities as well as optimal treatment strategies need to be devised. Drs. Mike Fradley and Joerg Herrmann explain.

 

Up Next Autoplay